Transthyretin amyloidosis (ATTR amyloidosis) is a life-threatening disease caused by the deposition of misfolded transthyretin (TTR) protein amyloid fibrils in various tissues, leading to polyneuropathy and/or cardiomyopathy, among other clinical manifestations [1,2]. This evidence concerns the gene TTR and polyneuropathy.